TY  - JOUR

T1  - The vedex regimen: An effective and well tolerated palliative treatment for non-Hodgkin's lymphoma (NHL)

JO  - European Journal of Cancer

PY  - 1997/09/07

AU  - El-Helw L

AU  - Lorigan PC

AU  - Coleman RE

AU  - Hancock BW

ED  - 

DO  - DOI: 10.1016/s0959-8049(97)86111-4

PB  - Elsevier BV

VL  - 33

SP  - S266

EP  - S266

Y2  - 2025/10/10

ER  -